Abstract | BACKGROUND: Progression time from islet autoimmunity to clinical type 1 diabetes is highly variable and the extent that genetic factors contribute is unknown. METHODS: In 341 islet autoantibody-positive children with the human leucocyte antigen (HLA) DR3/DR4-DQ8 or the HLA DR4-DQ8/DR4-DQ8 genotype from the prospective TEDDY (The Environmental Determinants of Diabetes in the Young) study, we investigated whether a genetic risk score that had previously been shown to predict islet autoimmunity is also associated with disease progression. RESULTS: Islet autoantibody-positive children with a genetic risk score in the lowest quartile had a slower progression from single to multiple autoantibodies (p=0.018), from single autoantibodies to diabetes (p=0.004), and by trend from multiple islet autoantibodies to diabetes (p=0.06). In a Cox proportional hazards analysis, faster progression was associated with an increased genetic risk score independently of HLA genotype (HR for progression from multiple autoantibodies to type 1 diabetes, 1.27, 95% CI 1.02 to 1.58 per unit increase), an earlier age of islet autoantibody development (HR, 0.68, 95% CI 0.58 to 0.81 per year increase in age) and female sex (HR, 1.94, 95% CI 1.28 to 2.93). CONCLUSIONS:
|
Authors | Andreas Beyerlein, Ezio Bonifacio, Kendra Vehik, Markus Hippich, Christiane Winkler, Brigitte I Frohnert, Andrea K Steck, William A Hagopian, Jeffrey P Krischer, Åke Lernmark, Marian J Rewers, Jin-Xiong She, Jorma Toppari, Beena Akolkar, Stephen S Rich, Anette-G Ziegler, TEDDY Study Group |
Journal | Journal of medical genetics
(J Med Genet)
Vol. 56
Issue 9
Pg. 602-605
(09 2019)
ISSN: 1468-6244 [Electronic] England |
PMID | 30287597
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. |
Chemical References |
|
Topics |
- Autoantibodies
(immunology)
- Autoimmunity
- Child
- Child, Preschool
- Diabetes Mellitus, Type 1
(genetics, immunology, pathology)
- Disease Progression
- Female
- Genetic Predisposition to Disease
- Humans
- Infant
- Islets of Langerhans
(immunology, metabolism, pathology)
- Male
- Prospective Studies
- Risk Assessment
- Risk Factors
|